- Home
- PRGO vs ENHA Comparison
PRGO vs ENHA Comparison
Compare PRGO & ENHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$9.95
N/A
Current Price
$2.84
Company Overview
Basic Information| Metric | PRGO | ENHA |
|---|---|---|
| Founded | 1887 | N/A |
| Country | Ireland | Singapore |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Services-Misc. Amusement & Recreation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.4B |
| IPO Year | 2013 | N/A |
Fundamental Metrics
Financial Performance| Metric | PRGO | ENHA |
|---|---|---|
| Price | $9.95 | $2.84 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $19.33 | N/A |
| AVG Volume (30 Days) | ★ 3.2M | 678.9K |
| Earning Date | 05-06-2026 | N/A |
| Dividend Yield | ★ 10.28% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $800,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.02 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $9.23 | $2.88 |
| 52 Week High | $28.44 | $4.60 |
Technical Indicators
Market Signals| Indicator | PRGO | ENHA |
|---|---|---|
| Relative Strength Index (RSI) | 38.80 | N/A |
| Support Level | $9.24 | N/A |
| Resistance Level | $11.88 | N/A |
| Average True Range (ATR) | 0.59 | 0.00 |
| MACD | -0.10 | 0.00 |
| Stochastic Oscillator | 16.05 | 0.00 |
Price Performance
Historical Comparison PRGO
ENHA
About PRGO Perrigo Company plc
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.